Ironic technology: Old age and the implantable cardioverter defibrillator in US health care

Social Science and Medicine

Volumn 72, Issue 1, 2011, Pages 6-14

  Kaufman, Sharon R ^a   Mueller, Paul S ^b   Ottenberg, Abigale L ^b   Koenig, Barbara A ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Aging society; Ethics and policy; Heart failure; Medical technology; Risk prevention; US health care; USA

Indexed keywords

AGING POPULATION; CARDIOVASCULAR DISEASE; ETHICS; HEALTH CARE; HEALTH POLICY; RISK FACTOR; TECHNOLOGICAL DEVELOPMENT;

ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; DEFIBRILLATOR; DYING; ELDERLY CARE; ETHNOGRAPHY; FAMILY; HEALTH INSURANCE; HEART ARRHYTHMIA; HEART FAILURE; HEART RHYTHM; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTATION; MEDICAL DECISION MAKING; MEDICAL ETHICS; MEDICARE; PATIENT ATTITUDE; PATIENT RIGHT; REIMBURSEMENT; RESUSCITATION; RISK REDUCTION; SUDDEN DEATH; SURVIVAL; TECHNOLOGY; TREATMENT INDICATION; TREATMENT REFUSAL; UNITED STATES;

AGED, 80 AND OVER; BIOETHICAL ISSUES; BIOMEDICAL ENHANCEMENT; CHOICE BEHAVIOR; CULTURAL CHARACTERISTICS; DEFIBRILLATORS, IMPLANTABLE; DELIVERY OF HEALTH CARE; EVIDENCE-BASED MEDICINE; HEART FAILURE; HUMANS; LONGEVITY; PATIENT PARTICIPATION; PHYSICIAN-PATIENT RELATIONS; RISK ASSESSMENT; UNITED STATES;

UNITED STATES;

EID: 78650171427     PISSN: 02779536     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.socscimed.2010.09.052     Document Type: Article

References (64)

1. Armstrong D. Professionalism, indeterminacy and the EBM project. BioSocieties 2007, 2(1):73-84.
2. Bristow M.R., Saxon L.A., Boehmer J., Krueger S., Kass D.A., De Marco T., et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004, 350(21):2140-2150.
3. Buxton A.E. Implantable cardioverter-defibrillators should be used routinely in the elderly. The American Journal of Geriatric Cardiology 2007, 15(6):361-364.
4. Callahan D. Taming the beloved beast: How medical technology costs are destroying our health care system 2009, Princeton University Press, Princeton.
5. Cassell E.J. The nature of suffering and the goals of medicine 1991, Oxford University Press, New York.
6. Chan P.S., Nallamothu B.K., Spertus J.A., Masoudi F.A., Bartone C., Kereiakes D.J., et al. Impact of age and medical comorbidity on the effectiveness of implantable cardioverter-defibrillators for primary prevention. Circ Cardiovasc Qual Outcomes 2009, 2(1):16-24.
7. Biventricular pacemaker 2010, Cleveland Clinic, (Cleveland).
8. de Lissovoy G. The implantable cardiac defibrillator: is the glass half empty or half full?. Med Care 2007, 45(5):371-373.
9. Dickerson S.S. Redefining life while forestalling death: living with an implantable cardioverter defibrillator after a sudden cardiac death experience. Qualitative Health Research 2002, 12(3):360.
10. Drought T.S., Koenig B.A. 'Choice' in end of life decision-making: Researching fact of fiction?. Gerontologist 2002, 42(special issue no. 3):114-128.
11. Eckert M., Jones T. How does an implantable cardioverter defibrillator (ICD) affect the lives of patients and their families?. Int J Nurs Pract 2002, 8(3):152-157.
12. Emanuel E.J., Fuchs V.R. The perfect storm of overutilization. Jama 2008, 299(23):2789-2791.
13. Fairfield H. Health spending vs. results. New York Times July 6 2010.
14. Fleck L.M. Is age-based rationing ever "Just enough"? Just caring: Health care rationing and democratic deliberation 2009, Oxford University Press, New York.
15. Fuchs V.R. The growing demand for medical care. N Engl J Med 1968, 279(4):190-195.
16. Gawande A. Letting go. The New Yorker 2010, 36-49.
17. Gillick M.R. Medicare coverage for technological innovations-time for new criteria?. N Engl J Med 2004, 350(21):2199-2203.
18. Gillick M.R. The technological imperative and the battle for the hearts of America. Perspect Biol Med 2007, 50(2):276-294.
19. Goldenberg I., Moss A.J., Hall W.J., McNitt S., Zareba W., Andrews M.L., et al. Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the multicenter automatic defibrillator implantation trial II. Circulation 2006, 113(24):2810-2817.
20. Goldstein N.E., Lynn J. Trajectory of end-stage heart failure: the influence of technology and implications for policy change. Perspect Biol Med 2006, 49(1):10-18.
21. Goldstein N.E., Mehta D., Siddiqui S., Teitelbaum E., Zeidman J., Singson M., et al. That's like an act of suicide" patients' attitudes toward deactivation of implantable defibrillators. J Gen Intern Med 2008, 1(23 Suppl):7-12.
22. Goldstein N.E., Mehta D., Teitelbaum E., Bradley E.H., Morrison R.S. "It's like crossing a bridge" complexities preventing physicians from discussing deactivation of implantable defibrillators at the end of life. J Gen Intern Med 2008, 1(23 Suppl):2-6.
23. Goodman N.W. What is it acceptable to die of. Bmj 1997, 314(7092):1484.
24. Gordon D. Tenacious assumptions in Western medicine. Biomedicine examined 1988, 19-56. Kluwer Academic Publishers, Boston. M.M. Lock, D. Gordon (Eds.).
25. Grant M. Ethical and attitudinal considerations for critical care nurses regarding deactivation of implantable cardioverter-defibrillators. AACN Adv Crit Care 2010, 21(2):222-226.
26. Hammersley M., Atkinson P. Ethnography: principles in practice 1995, Routledge, London ; New York.
27. Hammill S.C., Kremers M.S., Stevenson L.W., Heidenreich P.A., Langn C.M., Curtis J.P., et al. National ICD Registry annual report 2009 review of the Registry's Fourth year, Incorporating lead data and Pediatric ICD procedures, and use as a National Performance Measure. Heart Rhythm 2010.
28. Healey J., Connolly S. Life and death after ICD implantation. N Engl J Med 2008, 359(10):1058-1059.
29. Heath I. What do we want to die from?. Bmj 2010, 341:181.
30. Heidenreich P.A., Tsai V. Is anyone too old for an implantable cardioverter-defibrillator?. Circ Cardiovasc Qual Outcomes 2009, 2(1):6-8.
31. Hlatky M.A. Evidence-based use of cardiac procedures and devices. N Engl J Med 2004, 350(21):2126-2128.
32. Jeffrey K. Machines in our hearts: The cardiac pacemaker, the implantable defibrillator, and American health care 2001, Johns Hopkins University Press, Baltimore.
33. Kamphuis H.C.M., Verhoeven N., Leeuw R., Derksen R., Hauer R.N.W., Winnubst J.A.M. ICD: a qualitative study of patient experience the first year after implantation. J Clin Nurs 2004, 13(8):1008-1016.
34. Katz S., Marshall B. New sex for old: lifestyle, consumerism, and the ethics of aging well. Journal of Aging Studies 2003, 17(1):3-16.
35. Kaufman S.R. In the shadow of "death with dignity": medicine and cultural quandaries of the vegetative state. American Anthropologist 2000, 102(1):69-83.
36. Kaufman S.R. -And a time to die: How American hospitals shape the end of life 2005, Scribner, New York.
37. Kaufman S.R., Shim J.K., Russ A.J. Revisiting the biomedicalization of aging: clinical trends and ethical challenges. Gerontologist 2004, 44(6):731-738.
38. Kaufman S.R., Shim J.K., Russ A.J. Old age, life extension, and the character of medical choice. J Gerontol B Psychol Sci Soc Sci 2006, 61(4):S175-S184.
39. Kirkpatrick J.N., Kim A.Y. Ethical issues in heart failure. Perspect Biol Med 2006, 49(1):1-9.
40. Koenig B. The technological Imperitives in medical practice. Biomedicine examined 1988, 465-496. Kluwer Academic Publishers, Boston. M.M. Lock, D. Gordon (Eds.).
41. Krahn A.D., Connolly S.J., Roberts R.S., Gent M. Diminishing proportional risk of sudden death with advancing age: implications for prevention of sudden death. Am Heart J 2004, 147(5):837-840.
42. Latour B., Venn C. Morality and technology: the end of the means. Theory, Culture and Society 2002, 19(5/6):247-260.
43. Lubitz J. Health, technology, and medical care spending. Health Aff (Millwood) 2005, 24(Suppl 2). W5R81-W5R85.
44. McClellan M.B., Tunis S.R. Medicare coverage of ICDs. N Engl J Med 2005, 352(3):222-224.
45. Meier B. Lifesaving devices can cause Havoc at Life's end 2010, The New York Times, New York.
46. Mol A. The logic of care: Health and the problem of patient choice 2008, Routledge, London.
47. Mueller P.S., Jenkins S.M., Bramstedt K.A., Hayes D.L. Deactivating implanted cardiac devices in terminally ill patients: practices and attitudes. Pacing Clin Electrophysiol 2008, 31(5):560-568.
48. Myerburg R.J. Impantable cardioverter-defibrillators after myocardial infarction. N Engl J Med 2008, 359(21):2245-2253.
49. Pacemakers: the new generation. Today's implantable units do far more than previous models. The Cleveland Clinic Heart Advisor 2006, 9(4):6.
50. Pollock A. The internal cardiac defibrillator. The inner history of devices 2008, 98-111. MIT Press, Cambridge, Mass. S. Turkle (Ed.).
51. Poole J.E., Johnson G.W., Hellkamp A.S., Anderson J., Callans D.J., Raitt M.H., et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 2008, 359(10):1009-1017.
52. Redberg R.F. Disparities in use of implantable cardioverter-defibrillators: moving beyond process measures to outcomes data. Jama 2007, 298(13):1564-1566.
53. Rose N. The politics of life itself: biomedicine, power, and subjectivity in the twenty-first century 2007, Princeton University Press, Princeton, NJ.
54. Rosenberg C.E. Our present complaint: American medicine, then and now 2007, Johns Hopkins University Press, Baltimore.
55. Shim J.K., Russ A.J., Kaufman S.R. Risk, life extension and the pursuit of medical possibility. Sociology of Health & Illness 2006, 28(4):479-502.
56. Shim J.K., Russ A.J., Kaufman S.R. Clinical life: expectation and the double edge of medical promise. Health (London) 2007, 11(2):245-264.
57. Sulmasy D.P. Within you/without you: biotechnology, ontology, and ethics. Journal of General Internal Medicine 2007, 23:69-72.
58. Swindle J.P., Rich M.W., McCann P., Burroughs T.E., Hauptman P.J. Implantable cardiac device procedures in older patients: use and in-hospital outcomes. Arch Intern Med 2010, 170(7):631-637.
59. Timmermans S. Sudden death and the myth of CPR 1999, Temple University Press, Philadelphia.
60. Tunis S.R. Why Medicare has not established criteria for coverage decisions. N Engl J Med 2004, 350(21):2196-2198.
61. Tung R., Swerdlow C.D. Refining patient selection for primary prevention implantable cardioverter-defibrillator therapy: reeling in a net cast too widely. Circulation 2009, 120(10):825-827.
62. Weber M.A., Wenger N.K., Scheidt S. Who should be treated with implantable cardioverter-defibrillators?. The American Journal of Geriatric Cardiology 2006, 15(6):336-337.
63. Withell B. Patient consent and implantable cardioverter defibrillators: some palliative care implications. Int J Palliat Nurs 2006, 12(10):470-475.
64. Yarnoz M.J., Curtis A.B. Why cardioverter-defibrillator implantation might not be the best idea for your elderly patient. The American Journal of Geriatric Cardiology 2007, 15(6):367-371.